Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oraya Therapeutics
San Francisco*, California, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Oraya’s IRay system is a non-invasive, robotically controlled stereotactic radiotherapy device delivering low-energy X-rays to the back of the eye. Clinical trials demonstrated that a single treatment could reduce or eliminate the need for anti–VEGF injections in wet AMD while maintaining or improving vision outcomes. The INTREPID trial was a sham-controlled, double-masked study supporting efficacy and safety. The platform received CE Mark approval for both wet AMD and choroidal metastases by 2015[7][10].
- Therapeutic areas
- OncologyOphthalmology
- Modalities
- DeviceNon-pharmacological therapy (robotically controlled low-energy X-ray radiotherapy system)
- Industry
- Therapeutic Medical Devices
02
Partnerships
No specific partnerships with major pharma disclosed; collaborations with leading ophthalmologists and academic centers noted during development and clinical validation phases[10].
Beyond the preview
Go deeper on Oraya Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oraya Therapeutics.